🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎤#17ICML Plenary session "Frontline intensified ABVD demonstrates superior efficacy than PET-adapted ABVD in advanced HL: the FIL-Rouge Phase 3 Trial by the Fondazione Italiana Linfomi" A. Pinto (Naples, IT) 👉🏻Check out the complete Scientific Program: bit.ly/3IlOc7h

🎤#17ICML Plenary session "Nivolumab(N)-AVD Improves Progression-Free Survival Compared to Brentuximab Vedotin(BV)-AVD in Advanced Stage (AS) Classic Hodgkin Lymphoma (HL): Results of SWOG S1826" A. F. Herrera (Duarte, CA, US 🔗Complete Scientific Program: bit.ly/3IlOc7h

Lugano is getting ready for #17ICML💪!

🏃🏻Join the «Corsa della speranza (Run for Hope)», a charity run organized in collaboration with «La Corsa della speranza» during the 17-ICML with the aim to collect funds for cancer research projects carried out in Southern Switzerland. 🔗bit.ly/41xm7S9

🎤#17-ICML Late Breaking Abstracts Session The content of the #17ICML Late Breaking Abstracts Session (Saturday, June 17, 10:15 - 11:30) is now online! 👉🏻 Discover the presentations here: shorturl.at/lvF38

📖 The #17ICML Abstract and Educational Books, supplements to "Hematological Oncology" (John Wiley and Sons, Inc.), are online! 🔗 Abstract Book: shorturl.at/qF145 🔗 Educational Book: t.ly/8NZm

See you tomorrow at the #17ICML !

formal ⁦International Conference on Malignant Lymphoma⁩ #icml17 opening!

🔍💼 CALL FOR NEW GROUP LEADER AT THE IOR The IOR is looking for a Group Leader in Lymphoma Biology and Therapy. More information: bit.ly/3WaG8fk

Thank you for attending the #17ICML! A huge "thank you" also to our Advisory Board, Reviewers, Faculty, cooperating Scientific Societies AACR ESOncology ESMO - Eur. Oncology and Sponsors for their precious support. See you in 2025!

#IORnews The Lymphoma Genomics Lab, guided by Prof. Bertoni Francesco Bertoni identified a new mechanism behind the resistance to BTK and PI3K inhibitors used in the treatment of follicular lymphoma, mantle cell lymphoma and marginal zone lymphoma. 🔗The news: shorturl.at/ouwJ8

#IORnews We are honored to announce that the IOR Foundation President, Prof. Franco Cavalli, will receive the "Award for Lifetime Achievement" from the AACR in recognition of his outstanding contributions to oncology. 🔗Read the news: usi.ch/en/feeds/27552

Deadline Extended: Submit an abstract by April 19 for the Fourth AACR International Meeting on Advances in Malignant Lymphoma (June 19-22, Philadelphia), chaired by Michael R. Green and organized in association with Blood Cancer Discovery. bit.ly/3vxlOfk #AACRlymph24 Michael Green, PhD

📢Registration to the 18-ICML is open! Don't miss the opportunity to participate in the only international conference that focuses exclusively on #lymphoidneoplasms! 🔗Register now: shorturl.at/LHtyT

📢Registration for the 2025 Lymphoma Forum of Excellence is open! Join this annual meeting in Bellinzona, Switzerland. Designed by lymphoma experts, the program offers updated knowledge and multidisciplinary case discussions. 🔗Info and registration: lymphomaforum.ch

📢 📄 The abstract submission for the #18ICML is officially OPEN! Abstracts can be related to all aspects of the biology and treatment of #lymphoidneoplasms, including #CLL and #multiplemyeloma. More info: bit.ly/3ZBwOU3 #lymsm #lymphoma #myeloma

⌛ Only one month left to take advantage of the #18ICML early registration fee (February 28)! More information: icml.ch/icml/congresse… #lymphoma #lymsm #CLL #myeloma

⏰Only one week left to take advantage of the #18ICML early registration fee! (deadline: 28 February 2025) 🔗Register here: icml.ch/icml/congresse… #lymphoma #lymsm #CLL #myeloma

⏳ Last week for 18-ICML abstract submission! (deadline 15 March at 17:59 CET). 📊 Late-breaking abstracts: covering letters due by 15 March at 17:59 CET. 👉icml.ch/icml/congresse… #lymphoma #lymsm #CLL #myeloma

We are on Bluesky now! Come find us → International Conference on Malignant Lymphoma.bsky.social